MicroRNAs: novel tools to block gut inflammation in HIV?
作者信息
Klatt Nichole R, Hunt Peter W
机构信息
aDepartment of Pharmaceutics, Washington National Primate Research Center, University of Washington, Seattle, Washington bDepartment of Medicine, University of California, San Francisco, San Francisco, California, USA.
出版信息
AIDS. 2017 Sep 10;31(14):2017-2018. doi: 10.1097/QAD.0000000000001609.
Abstract
摘要
相似文献
1
MicroRNAs: novel tools to block gut inflammation in HIV?微小RNA：阻断HIV肠道炎症的新工具？
AIDS. 2017 Sep 10;31(14):2017-2018. doi: 10.1097/QAD.0000000000001609.
2
Unique microRNA expression in the colonic mucosa during chronic HIV-1 infection.慢性 HIV-1 感染期间结肠黏膜中的独特 microRNA 表达。
AIDS. 2017 Sep 10;31(14):1925-1934. doi: 10.1097/QAD.0000000000001582.
3
Macrophages accumulate in the gut mucosa of untreated HIV-infected patients.未治疗的 HIV 感染患者的肠道黏膜中会积聚巨噬细胞。
J Infect Dis. 2014 Mar 1;209(5):739-48. doi: 10.1093/infdis/jit547. Epub 2013 Oct 16.
4
Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials.益生菌能否减轻HIV感染者的炎症并增强肠道免疫健康：炎症与易位益生菌维百安（PROOV IT）试验的研究设计。
HIV Clin Trials. 2016 Jul;17(4):147-57. doi: 10.1080/15284336.2016.1184827. Epub 2016 Jun 7.
5
MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers-their effects and therapeutic potentials.肠道屏障功能、炎症性肠病和相关癌症中的 microRNAs——它们的作用和治疗潜力。
Curr Opin Pharmacol. 2017 Dec;37:142-150. doi: 10.1016/j.coph.2017.10.010. Epub 2017 Nov 15.
6
Dietary Gluten-Induced Gut Dysbiosis Is Accompanied by Selective Upregulation of microRNAs with Intestinal Tight Junction and Bacteria-Binding Motifs in Rhesus Macaque Model of Celiac Disease.在乳糜泻恒河猴模型中，饮食中的麸质诱导肠道菌群失调，同时伴有具有肠道紧密连接和细菌结合基序的微小RNA选择性上调。
Nutrients. 2016 Oct 28;8(11):684. doi: 10.3390/nu8110684.
7
[HIV infection and chronic inflammation: is the bacterial translocation the underlying cause?].[HIV感染与慢性炎症：细菌易位是根本原因吗？]
Med Clin (Barc). 2012 May 26;138(15):673-7. doi: 10.1016/j.medcli.2011.11.010. Epub 2012 Feb 23.
8
Th17 cells, HIV and the gut mucosal barrier.辅助性 T 细胞 17、HIV 和肠道黏膜屏障。
Curr Opin HIV AIDS. 2010 Mar;5(2):173-8. doi: 10.1097/COH.0b013e328335eda3.
9
Mucosal immunity in HIV infection: what can be done to restore gastrointestinal-associated lymphoid tissue function?HIV感染中的黏膜免疫：如何恢复胃肠道相关淋巴组织功能？
Curr Opin Infect Dis. 2014 Jun;27(3):275-81. doi: 10.1097/QCO.0000000000000059.
10
Gut mucosa in HIV infection: "immune milk" solution.HIV感染中的肠道黏膜：“免疫乳”解决方案。
PLoS Med. 2007 Feb;4(2):e85. doi: 10.1371/journal.pmed.0040085.
本文引用的文献
1
Unique microRNA expression in the colonic mucosa during chronic HIV-1 infection.慢性 HIV-1 感染期间结肠黏膜中的独特 microRNA 表达。
AIDS. 2017 Sep 10;31(14):1925-1934. doi: 10.1097/QAD.0000000000001582.
2
Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.急性HIV感染期开始抗逆转录病毒治疗的患者中存在持续的慢性炎症，尽管炎症程度有所减轻。
Clin Infect Dis. 2017 Jan 15;64(2):124-131. doi: 10.1093/cid/ciw683. Epub 2016 Oct 12.
3
Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy.白细胞介素-6和D-二聚体与接受抑制性抗逆转录病毒治疗的HIV阳性成年人严重非艾滋病发病率和死亡率的相关性。
PLoS One. 2016 May 12;11(5):e0155100. doi: 10.1371/journal.pone.0155100. eCollection 2016.
4
Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286.利福昔明对接受抗逆转录病毒治疗的HIV阳性免疫无反应者（ACTG A5286研究）的微生物易位、T细胞活化及炎症仅有轻微影响。
J Infect Dis. 2015 Mar 1;211(5):780-90. doi: 10.1093/infdis/jiu515. Epub 2014 Sep 11.
5
Early mucosal sensing of SIV infection by paneth cells induces IL-1β production and initiates gut epithelial disruption.潘氏细胞对猴免疫缺陷病毒感染的早期黏膜感知诱导白细胞介素-1β产生并引发肠道上皮破坏。
PLoS Pathog. 2014 Aug 28;10(8):e1004311. doi: 10.1371/journal.ppat.1004311. eCollection 2014 Aug.
6
Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection.司维拉姆不会降低未接受治疗的HIV感染者的脂多糖或可溶性CD14水平，但会降低可溶性组织因子、低密度脂蛋白（LDL）胆固醇和氧化LDL胆固醇水平。
J Infect Dis. 2014 Nov 15;210(10):1549-54. doi: 10.1093/infdis/jiu305. Epub 2014 May 26.
7
Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.炎症和凝血的可溶性标志物而非T细胞活化可预测抗逆转录病毒抑制治疗期间的非艾滋病定义性病态事件。
J Infect Dis. 2014 Oct 15;210(8):1248-59. doi: 10.1093/infdis/jiu254. Epub 2014 May 1.
8
Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection.肠道上皮屏障功能障碍和先天免疫激活可预测接受治疗的HIV感染患者的死亡率。
J Infect Dis. 2014 Oct 15;210(8):1228-38. doi: 10.1093/infdis/jiu238. Epub 2014 Apr 21.
9
Microbial translocation, immune activation, and HIV disease.微生物易位、免疫激活与 HIV 疾病。
Trends Microbiol. 2013 Jan;21(1):6-13. doi: 10.1016/j.tim.2012.09.001. Epub 2012 Oct 11.
10
The Role of MicroRNA in Inflammatory Bowel Disease.微小RNA在炎症性肠病中的作用
Gastroenterol Hepatol (N Y). 2010 Nov;6(11):714-22.
Zotero 插件